Marksans Pharma Ltd vs Viyash Scientific Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Marksans Pharma Ltd is ₹ 189.4 as of 04 May 10:42 . The P/E Ratio of Marksans Pharma Ltd changed from 8.7 on March 2021 to 26.5 on March 2025 . This represents a CAGR of 24.95% over 5 yearsThe P/E Ratio of Viyash Scientific Ltd changed from 62.7 on March 2021 to 150.3 on March 2025 . This represents a CAGR of 19.11% over 5 years The Market Cap of Marksans Pharma Ltd changed from ₹ 2044 crore on March 2021 to ₹ 10076 crore on March 2025 . This represents a CAGR of 37.58% over 5 yearsThe Market Cap of Viyash Scientific Ltd changed from ₹ 5983 crore on March 2021 to ₹ 3273 crore on March 2025 . This represents a CAGR of -11.36% over 5 years The revenue of Marksans Pharma Ltd for the Dec '25 is ₹ 774.57 crore as compare to the Sep '25 revenue of ₹ 741.98 crore. This represent the growth of 4.39% The revenue of Viyash Scientific Ltd for the Dec '25 is ₹ 872.39 crore as compare to the Sep '25 revenue of ₹ 857.76 crore. This represent the growth of 1.71% The ebitda of Marksans Pharma Ltd for the Dec '25 is ₹ 180.89 crore as compare to the Sep '25 ebitda of ₹ 166.07 crore. This represent the growth of 8.92% The ebitda of Viyash Scientific Ltd for the Dec '25 is ₹ 148.35 crore as compare to the Sep '25 ebitda of ₹ 178.99 crore. This represent the decline of -17.12% The net profit of Marksans Pharma Ltd changed from ₹ 89.07 crore to ₹ 113.69 crore over 7 quarters. This represents a CAGR of 14.97% The net profit of Viyash Scientific Ltd changed from ₹ 9.06 crore to ₹ 48.52 crore over 7 quarters. This represents a CAGR of 160.89% The Dividend Payout of Marksans Pharma Ltd changed from 10.4 % on March 2021 to 19.26 % on March 2025 . This represents a CAGR of 13.12% over 5 yearsThe Dividend Payout of Viyash Scientific Ltd changed from 38.67 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Marksans Pharma Ltd

Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982.
Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005.
The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
Marksans Pharma Limited (formerly M/s.

About Viyash Scientific Ltd

Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself.
The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.

FAQs for the comparison of Marksans Pharma Ltd and Viyash Scientific Ltd

Which company has a larger market capitalization, Marksans Pharma Ltd or Viyash Scientific Ltd?

Market cap of Marksans Pharma Ltd is 8,367 Cr while Market cap of Viyash Scientific Ltd is 8,918 Cr

What are the key factors driving the stock performance of Marksans Pharma Ltd and Viyash Scientific Ltd?

The stock performance of Marksans Pharma Ltd and Viyash Scientific Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Marksans Pharma Ltd and Viyash Scientific Ltd?

As of May 4, 2026, the Marksans Pharma Ltd stock price is INR ₹184.65. On the other hand, Viyash Scientific Ltd stock price is INR ₹204.15.

How do dividend payouts of Marksans Pharma Ltd and Viyash Scientific Ltd compare?

To compare the dividend payouts of Marksans Pharma Ltd and Viyash Scientific Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.